SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism

NCT07482020 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

66

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation (AF)
Hypertension

Interventions

DRUG: SGLT-2 inhibitors
DRUG: Placebo

Sponsor

Huashan Hospital

Collaborators

[object Object]
[object Object]